| 126618 |
THE ONCOLOGIST |
Weekly Paclitaxel/Carboplatin/Trastuzumab Therapy Improves Pathologic Complete Remission in Aggressive HER2-Positive Breast Cancers, Especially in Luminal-B Subtype, Compared With a Once-Every-3-Weeks Schedule |
2013-05-01 |
10.1634/theoncologist.2012-0057 |
Yu K.-D., Liu G.-Y., Chen C.-M., Li J.-W., Wu J., Lu J.-S., Shen Z.-Z., Shao Z.-M. |
| 126617 |
BMC MUSCULOSKELETAL DISORDERS |
Spectrum of Pompe disease in childhood - The Toronto experience |
2013-05-01 |
10.1186/1471-2474-14-s2-p3 |
Raiman J, Bendiak G, Hewson S, Mecija M, Narang I, Saunders M |
| 126616 |
BMC MUSCULOSKELETAL DISORDERS |
Clinical, morphological and genetic features of a cohort of late onset GSD II patients: typical and atypical presentations |
2013-05-01 |
10.1186/1471-2474-14-s2-p9 |
Barca E, Musumeci O, Rodolico C, Ciranni A, Vita G, Toscano A |
| 126615 |
F1000RESEARCH |
Morgellons: a novel dermatological perspective as the multisystem infective disease borreliosis |
2013-05-01 |
10.12688/f1000research.2-118.v1 |
Mayne Peter, English John S, Kilbane Edward J, Burke Jennie M, Middelveen Marianne J, Stricker Raphael B |
| 126614 |
BMC MUSCULOSKELETAL DISORDERS |
Heterozygous individuals with mild phenotype in late-onset glycogen storage disease type 2: a new cohort of patients? |
2013-05-01 |
10.1186/1471-2474-14-s2-p12 |
Vercelli L, Vittonatto E, Grifoni S, Chiadò-Piat L, Rolle E, Spada M, Danesino C, Comi G, Mongini T |
| 126613 |
THE ONCOLOGIST |
First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER |
2013-05-01 |
10.1634/theoncologist.2012-0414 |
Tripathy D., Kaufman P. A., Brufsky A. M., Mayer M., Yood M. U., Yoo B., Quah C., Yardley D., Rugo H. S. |
| 126612 |
BMC MUSCULOSKELETAL DISORDERS |
Cytokines in treated and untreated Pompe patients |
2013-05-01 |
10.1186/1471-2474-14-s2-p6 |
Karabul N, Gökce S, Kirchner M, Mannhardt W, Mengel E |
| 126611 |
BMC MUSCULOSKELETAL DISORDERS |
Successful twin pregnancy in a 38-year-old woman with Pompe disease despite interruption of enzyme replacement therapy (ERT) |
2013-05-01 |
10.1186/1471-2474-14-s2-p8 |
Tiling N, Bosanska L, Gossing G, Krieg H, Krebs A, Rosseau S, Schütte H, Irlbacher K, Plöckinger U |
| 126610 |
THE ONCOLOGIST |
Unmet Needs in the Prediction and Detection of Metastases in Prostate Cancer |
2013-05-01 |
10.1634/theoncologist.2013-0027 |
Sartor O., Eisenberger M., Kattan M. W., Tombal B., Lecouvet F. |
| 126609 |
BMC MUSCULOSKELETAL DISORDERS |
Detection rate of Pompe disease in undiagnosed neuromuscular patients from four major centres in the UK - results of a 12 month prospective audit |
2013-05-01 |
10.1186/1471-2474-14-s2-p20 |
Willis Tracey, Roberts Mark, Hilton-Jones David, Quinlivan Ros, Hanna Mike, Straub Volker |
